Corrigendum to “Amygdalin in antineoplastic medicine and the relevance of nanotechnology” [Biomed. Pharmacother. 182 (2025) 117772]

Abstract

The authors regret not having expressed their gratitude to Qatar University for sponsoring the article processing charge. Authors now duly acknowledge Qatar University for sponsoring the article processing charge.